Atlas Trials

Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected Patients

Clinical trial NCT03256422 · COMPLETED

Trial details

NCT number
NCT03256422
Sponsor
ANRS, Emerging Infectious Diseases
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HIV Infections
Start date
2017-09-07
Primary completion
2019-08-06
Enrollment
640

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.